Found 22 articles for: "Rosacea"
A Cosmetic Regimen Formulated to Address the Multi-Modal Pathogenesis of Rosacea Demonstrates Efficacy for Treating Facial Redness and Skin's Appearance
September 2024 | Volume 23 | Issue 9 | Original Article | 757 | Copyright © September 2024
Background: The treatment of rosacea is complicated as there are multiple pathogenic factors in play resulting in a myriad of clinical signs and symptoms including facial redness...
Read MoreSarecycline as a Potential Treatment for Steroid-Induced Rosacea/Perioral Dermatitis: A Case Report
February 2024 | Volume 23 | Issue 2 | Case Reports | e55 | Copyright © February 2024
Narrow-Band Intense Pulsed Light as Treatment for Erythematotelangiectatic Rosacea: A Retrospective Study
November 2023 | Volume 22 | Issue 11 | Original Article | 1095 | Copyright © November 2023
Background: Erythematotelangiectatic rosacea can be successfully treated using various laser and light-based devices. However, the use of narrow-band intense pulsed light for the...
Read MoreTopical Ivermectin Is Associated With Improved Erythematotelangiectatic, Papulopustular, and Phymatous Rosacea in a Secondary Analysis
October 2023 | Volume 22 | Issue 10 | Editorials | 1063 | Copyright © October 2023
Rosacea has variable clinical presentation consisting of four overlapping phenotypes: erythematotelangiectatic, papulopustular, phymatous, and ocular.1 Rosacea's pathogenesis involves incre...
Read MoreReduction of Erythema in Moderate-Severe Rosacea by a Low Molecular Weight Heparan Sulfate Analog (HSA)
June 2023 | Volume 22 | Issue 6 | Original Article | 546 | Copyright © June 2023
Rosacea changes are a result of an immune mediated response and the angiogenic properties of the LL-37 peptide. This peptide induces an inflammatory signal that activates the NLRP3-mediated inflammaso...
Read MoreNeurogenic Rosacea Treatment: A Literature Review
June 2023 | Volume 22 | Issue 6 | Original Article | 566 | Copyright © June 2023
Rosacea is a chronic skin disorder involving central facial erythema secondary to vascular instability and cutaneous inflammation. Rosacea is divided into different subtypes based on the morpholo...
Read MoreCross-Sectional Study of Psoriasis, Atopic Dermatitis, Rosacea, and Alopecia Areata Suggests Association With Cardiovascular Diseases
June 2023 | Volume 22 | Issue 6 | Original Article | 576 | Copyright © June 2023
Background: A growing body of evidence suggests that several inflammatory skin diseases (ISDs) are associated with systemic inflammation and cardiovascular disease (CVDs)....
Read MorePlacement of High Dose Neurotoxins for Treatment-Resistant Rosacea
June 2023 | Volume 22 | Issue 6 | Case Reports | 605 | Copyright © June 2023
Rosacea is a chronic inflammatory skin condition characterized by facial flushing, erythema, telangiectasias, and papulopustular lesions. Treatment for rosacea includes limiting inciting factors ...
Read MoreTreatment and Maintenance of Cutaneous Rosacea in Latino Skin Types With Prescription Medications and Non-Prescription Cleansers and Moisturizers as Adjuncts: A Review
October 2022 | Volume 21 | Issue 10 | Original Article | 1111 | Copyright © October 2022
Background: Rosacea is an inflammatory dermatosis with at least a ten percent prevalence reported among white adults. Rosacea occurs in nonwhite populations, but prevalence data is li...
Read MoreImproving Rosacea Outcomes in Skin of Color Patients: A Review on the Nuances in the Treatment and the Use of Cleansers and Moisturizers
June 2022 | Volume 21 | Issue 6 | Original Article | 574 | Copyright © June 2022
Background: While rosacea is a common inflammatory condition that affects diverse populations, published data in skin of color (SOC) are limited. This review explored nuances in clini...
Read MoreUpdate on Facial Erythema in Rosacea
August 2021 | Volume 20 | Issue 8 | Original Article | 861 | Copyright © August 2021
Dermatologists are cognizant of the multiple clinical manifestations of rosacea, particularly persistent facial erythema, which has been deemed to be the most prevalent diagnostic feature and often po...
Read MoreEvaluation of a First-in-Class Proteasome Inhibitor in Patients With Moderate to Severe Rosacea
June 2021 | Volume 20 | Issue 6 | Original Article | 660 | Copyright © June 2021
Background: Novel, effective, affordable therapies for rosacea are needed. Innovative methods of assessing response for rosacea treatments are needed as well. This trial was designed ...
Read MoreVehicle Effects on the Rosacea Skin Barrier
June 2021 | Volume 20 | Issue 6 | Original Article | 630 | Copyright © June 2021
Background: Inflammatory papulopustular rosacea produces sensitive facial skin. Thus, medications designed for rosacea require careful vehicle development to insure optimal drug deliv...
Read MoreVirtual Exams No Substitute for In-Person Care of Acne and Rosacea
June 2020 | Volume 19 | Issue 6 | Editorials | 582 | Copyright © June 2020
Recognizing Rosacea: Tips on Differential Diagnosis
September 2019 | Volume 18 | Issue 9 | Original Article | 888 | Copyright © September 2019
Rosacea is a common chronic inflammatory dermatosis with a variety of clinical manifestations. Rosacea primarily affects the central face, and includes papules, pustules, erythema, telangiectasias, pe...
Read MoreA Biologically Based Approach to Acne and Rosacea
June 2018 | Volume 17 | Issue 6 | Original Article | 611 | Copyright © June 2018
Complementary and alternative medicine (CAM) therapies are increasing in popularity in the field of dermatology. Natural products and holistic approaches are in high demand among patients and research...
Read MoreManagement of Rosacea-Prone Skin: Evaluation of a Skincare Product Containing Ambophenol, Neurosensine, and La Roche-PosayThermal Spring Water as Monotherapy or Adjunctive Therapy
August 2013 | Volume 12 | Issue 8 | Original Article | 920 | Copyright © August 2013
OBJECTIVE: The objective of these studies was to investigate whether a skincare product containing Ambophenol, Neurosensine, and La Roche-Posay thermal spring water formulated in a highly protective p...
Read MoreEfficacy and Safety of Once-Daily Topical Brimonidine Tartrate Gel 0.5% for the Treatment of Moderate to Severe Facial Erythema of Rosacea: Results of Two Randomized, Double-blind, and Vehicle-Controlled Pivotal Studies
June 2013 | Volume 12 | Issue 6 | Original Article | 650 | Copyright © June 2013
BACKGROUND: Brimonidine tartrate, a highly selective α2-adrenergic receptor agonist with potent vasoconstrictive activity, was shown to reduce erythema of rosacea.
OBJECTIVE: To assess the ...
Read MoreEfficacy of Extended-Release 45 mg Oral Minocycline and Extended-Release 45 mg Oral Minocycline Plus 15% Azelaic Acid in the Treatment of Acne Rosacea
March 2013 | Volume 12 | Issue 3 | Original Article | 292 | Copyright © March 2013
Rosacea is one of the most commonly occurring dermatoses treated by dermatologists. There are multiple therapeutic options available for the treatment of papulopustular rosacea. Rosacea is an inflamma...
Read MoreWhy Is Rosacea Considered to Be an Inflammatory Disorder?
The Primary Role, Clinical Relevance, and Therapeutic Correlations of Abnormal Innate Immune Response in Rosacea-Prone SkinJune 2012 | Volume 11 | Issue 6 | Original Article | 694 | Copyright © June 2012
The pathophysiology of rosacea has undergone renewed interest over the past decade, with a large body of evidence suppo...
Read More
© 2023 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
